JAMA Health Forum Editors' Summary
by JAMA NetworkJAMA Health Forum is a peer-reviewed, open-access JAMA Network journal focused on health policy. The journal publishes original research, evidence-based reports, and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity, and reform. The podcast highlights new articles and their authors as well as the latest news in health policy for a broad audience interested in improving health and health care in the United States and globally.
Copyright: American Medical Association, 2021
Episodes
Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy
19m · PublishedBenjamin D. Sommers, MD, PhD, of Harvard University, speaks with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about differences in Medicaid enrollment as measured in surveys and administrative data. These differences have implications for estimating coverage now that the federal policy of continuous Medicaid eligibility during the COVID-19 pandemic has ended.
Related Content:
- Survey-Reported Coverage in 2019-2022 and Implications for Unwinding Medicaid Continuous Eligibility
Comparing Home Health Services in Traditional Medicare and Medicare Advantage
16m · PublishedJAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Rachel A. Prusynski, DPT, PhD, of the University of Washington about differences in the use and outcomes of home health services provided to beneficiaries in traditional Medicare and Medicare Advantage.
Related Content:
- Differences in Home Health Services and Outcomes Between Traditional Medicare and Medicare Advantage
Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic
13m · PublishedThe COVID-19 pandemic has caused major disruptions in ambulatory care. In this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical School discusses how access to care and preventive services changed for different racial and ethnic groups in the US from 2019 to 2022.
Related Content:
- Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity
Opioid Prescription Duration Limits
13m · PublishedJAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Lindsay D. Allen, PhD, about how setting-specific opioid prescription duration limits helped reduce opioid overuse in West Virginia.
Related Content:
- Opioid Prescribing Patterns After Imposition of Setting-Specific Limits on Prescription Duration
Trends in Smoking Among US Adults From 2011 to 2022
14m · PublishedSmoking remains a leading cause of preventable morbidity and mortality in the US. Rafael Meza, PhD, of the British Columbia Cancer Research Institute, discusses recent trends in smoking by US adults across different age and income groups in this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD.
Related Content:
- Trends in US Adult Smoking Prevalence, 2011 to 2022
The History, Economics, and Policy Context of Pharmacy Benefit Managers
14m · PublishedJAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, speak with Ge Bai, PhD, CPA, author of Pharmacy Benefit Managers: History, Business Practices, Economics, and Policy, about how pharmacy benefit managers (PBMs) have evolved in recent decades to play a central role in the US prescription drug market, including the benefits and policy challenges that PBMs present in this market.
Related Content:
- Pharmacy Benefit Managers
Economic Burden of Untreated Mental Illness in Indiana
15m · PublishedJAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, spoke with Heather Taylor, MD, from Indiana University Richard M. Fairbanks School of Public Health, about the costs of untreated mental illness in the state of Indiana. Considering a wide set of direct and indirect costs, her team estimated the cost to Indiana is over $4 Billon per year.
Related Content:
- Economic Burden Associated With Untreated Mental Illness in Indiana
Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy
21m · PublishedIn this interview, JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, explore with Erin K. McCreary, PharmD, and Atheendar S. Venkataramani, MD, PhD, how a large regional health system used a weighted lottery and intensive outreach to provide high-risk individuals in disadvantaged communities more equitable access to scarce monoclonal antibodies for preventing COVID-19.
Related Content:
- Weighted Lottery to Equitably Allocate Scarce Supply of COVID-19 Monoclonal Antibody
- Moving Beyond Intent and Realizing Health Equity
How Safe Were Kids in School During Phases of the Pandemic?
17m · PublishedJAMA Health Forum Editor John Ayanian, MD, and Deputy Editor Melinda Buntin, PhD, discuss with Sandra B. Nelson, MD (Massachusetts General Hospital, Boston), her JAMA Health Forum study of transmission of SARS-CoV-2 in schools in Massachusetts during 2 different phases of the COVID-19 pandemic. She found transmission rates were very low but varied by district and the availability of vaccines.
Related Content:
- Prevalence and Risk Factors for School-Associated Transmission of SARS-CoV-2
FDA Advisory Committees for New Prescription Drugs
20m · PublishedJAMA Health Forum Editor John Ayanian, MD, MPP, and Associate Editor Julie Donohue, PhD, speak with Aaron S. Kesselheim, MD, JD, MPH, and Genevieve P. Kanter, PhD, about the role of advisory committees convened by the US Food and Drug Administration (FDA) to guide its decisions on whether to approve new prescription drugs. They also consider how the FDA has responded to recommendations from these advisory committees over the past decade.
Related Content:
- Association of Advisory Committee Votes With US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021
- The Real Question the FDA Is Asking Its Advisory Committees
JAMA Health Forum Editors' Summary has 39 episodes in total of non- explicit content. Total playtime is 10:53:24. The language of the podcast is English. This podcast has been added on November 27th 2022. It might contain more episodes than the ones shown here. It was last updated on April 23rd, 2024 23:18.